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Abstract
The current paradigm of cyclin-dependent kinase (CDK) regulation based on the well-estab-
lished CDK2 has been recently expanded. The determination of CDK9 crystal structures
suggests the requirement of an additional regulatory protein, such as human immunodefi-
ciency virus type 1 (HIV-1) Tat, to exert its physiological functions. In most kinases, the
exact number and roles of the cofactor metal ions remain unappreciated, and the repertoire
has thus gained increasing attention recently. Here, molecular dynamics (MD) simulations
were implemented on CDK9 to explore the functional roles of HIV-1 Tat and the second Mg2
+ ion at site 1 (Mg1
2+). The simulations unveiled that binding of HIV-1 Tat to CDK9 not only
stabilized hydrogen bonds (H-bonds) between ATP and hinge residues Asp104 and
Cys106, as well as between ATP and invariant Lys48, but also facilitated the salt bridge net-
work pertaining to the phosphorylated Thr186 at the activation loop. By contrast, these H-
bonds cannot be formed in CDK9 owing to the absence of HIV-1 Tat. MD simulations further
revealed that the Mg1
2+ ion, coupled with the Mg2
2+ ion, anchored to the triphosphate moie-
ty of ATP in its catalytic competent conformation. This observation indicates the require-
ment of the Mg1
2+ ion for CDK9 to realize its function. Overall, the introduction of HIV-1 Tat
and Mg1
2+ ion resulted in the active site architectural characteristics of phosphorylated
CDK9. These data highlighted the functional roles of HIV-1 Tat and Mg1
2+ ion in the regula-
tion of CDK9 activity, which contributes an important complementary understanding of CDK
molecular underpinnings.
Introduction
Cyclin-dependent kinase 9 (CDK9) is a Ser/Thr kinase that belongs to the family of cyclin-de-
pendent kinases (CDKs). CDK9 serves as the catalytic subunit of the positive transcription
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elongation factor b (P-TEFb; CDK9/cyclin T), which phosphorylates the RNA polymerase II
C-terminal domain and the negative elongation factors NELF and DRB (dichlorobenzimida-
zole riboside)-sensitivity-inducing factor (DSIF) to trigger the elongation of many gene tran-
scripts [1]. P-TEFb has been an important therapeutic target in oncology, virology, and
cardiology [2,3]. A viral protein, human immunodeficiency virus type 1 (HIV-1) Tat, interacts
with P-TEFb and induces the factor to promote the productive elongation of HIV mRNA [4–
6]. Biochemical experiments have shown that Tat increased transcriptional elongation per-
formed by CDK9 [7].
Twenty CDK9 crystal structures have thus far been solved [8–18], and their availability
serves as a valuable resource for structure-aided drug design. CDK9 adopts a typical bilobal
fold (Fig 1A), which is extremely conserved among Ser/Thr and Tyr kinases. The N-terminal
lobe is composed of a five-stranded antiparallel β-sheet and one prominent α-helix, i.e., the
helix αC (sequence PITALRE in CDK9 and PSTAIRE in CDK2). The larger C-terminal lobe is
mostly helical and connected to the N-terminal lobe by the so-called flexible hinge region (resi-
dues 104–107). ATP is sandwiched between the N- and C-terminal lobes and anchors its ade-
nine moiety by H bonds with Asp104 and Cys106 in the hinge region. Cyclin T has a canonical
cyclin structure. The interface of CDK9/cyclin T is notably smaller than that of the CDK2/cy-
clin A complex and is restricted to the N-terminal lobe of CDK9.
Although a few kinases are known to harness a single divalent ion or none at all[19], many,
if not all, protein kinases require two divalent metal ions for optimum catalysis [20]. In the
kinome, the exact number and roles of the cofactor metal ions remain unknown, and the reper-
toires have recently gained increasing attention. Thus far, a few CDK9 crystal structures are as-
sociated with a single Mg2+ ion at site 2 (Mg2
2+ ion; Fig 1A and 1B), whereas the other Mg2+
ion at site 1 (Mg1
2+ ion) is absent in all CDK9 crystal structures. The crystal structures of
CDK2 with two Mg2+ ions had not been solved until recently, when the crystal structures of
CDK2/cyclin A transition state (TS) complex with two Mg2+ ions were discovered by Yong
et al. [21,22]. Experimental observations have demonstrated that Mg2+ concentration could
represent an important regulator of CDK2 activity in vivo [21]. These findings raise an inter-
esting question on whether CDK9 requires the binding of two Mg2+ ions to realize its function,
as in the case of CDK2.
CDK2 is a phenotypic family of CDKs. A series of CDK2/cyclin A structures have provided
significant insight into the molecular underpinnings of CDK activation and regulation. The
need of CDKs to be associated with a cognate cyclin, followed by phosphorylation on threonine
at the activation loop to realize full activity, is well-documented [23,24]. However, the generali-
ty of this underlying mechanism has been challenged with the determination of new CDK crys-
tal structures. For instance, the crystal structures of CDK4/cyclin D revealed that cyclin D
binding and activation loop phosphorylation do not adequately enable the CDK4 to adopt an
active conformation [24,25]. In fact, recent experiments underscored that association with ad-
ditional protein substrates and/or cofactor binding are critical to the remodeling of CDK4/cy-
clin D into its active conformation [25–27]. Additionally, the solved CDK9/cyclin T crystal
structures demonstrated some notable structural differences in the phosphorylated Thr186
(pThr186) at the activation loop. Although the phosphorylation of Thr186 is required for
CDK9 activation [28], pThr186 in CDK9/cyclin T1 complex crystal structures only forms salt
bridge interactions with Arg148 and Arg172. This condition is unlike that the CDK2/cyclin A
complex, in which pThr160 forms salt bridge interactions with the positively charged triad of
arginine residues (Arg50, Arg126, and Arg150). pThr186 is slightly distant (3.9 Å) from the
third arginine residue (Arg65), which is located in the αC helix (Fig 1A) [8]. Interestingly, as
shown in Fig 1B, the crystal structure of CDK9/cyclin T1 in a complex with a minimal activa-
tion domain (residues 1–48) of HIV-1 Tat formed five salt bridges with the arginine triad [9].
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HIV-1 Tat, a two-zinc-mediated viral transactivator of transcription, inserts itself into a groove
at the heterodimer interface, thus augmenting interactions and resulting in a more stable
P-TEFb complex. The reestablished Arg65–pThr186 ion pair results in a more stable local con-
formation and contributes to maintaining strong contact between the critical activation loop
and the prominent αC helix motif. The current understanding of kinase regulation owes much
to X-ray crystallography [29]. In this study, we performed 50 ns explicit-solvent MD simula-
tions on five different systems to determine the influence of HIV-1 Tat binding, activation loop
phosphorylation, and the presence of Mg1
2+ at site 1 on CDK9 dynamics. Our results revealed
elaborate and significant differences in the dynamics behavior of CDK9, which provides insight




The crystal structure of phosphorylated CDK9/cyclin T1 complex bound to ATP and one Mg2
+ ion at site 2 (Mg2
2+ ion) (pCDK9/cyclin T1/ATP/1MG complex) was obtained from the
RCSB Protein Data Bank (PDB code 3BLQ) [8] (Fig 1A). The first four simulation systems
were based on this crystal structure. The missing Mg2+ ion at site 1 (Mg1
2+ ion) was modeled
into its position by aligning the crystal structure of GSK3β in the complex with ATP analog
adenosine 50-(β,γ-imidotriphosphate) (AMP-PNP) and two Mg2+ ions (PDB code 1PYX) [30]
with the pCDK9/cyclin T1/ATP/1MG complex crystal structure. The Mg1
2+ ion is and subse-
quently extracted to model the pCDK9/cyclin T1/ATP/2MG complex. The pThr186 at the ac-
tive loop of the two complexes was replaced with nonphosphorylated Thr186 to construct the
CDK9/cyclin T1/ATP/1MG and CDK9/cyclin T1/ATP/2MG complexes. The fifth simulated
complex was based on another crystal structure of pCDK9/cyclin T1 in the complex with
AMP-PNP and Mg2
2+ ion and the minimal activation domain (residues 1–48) of HIV-1 Tat
(pCDK9/cyclin T1/AMP-PNP/1MG/Tat complex; PDB code 3MIA) [9] (Fig 1B). The missing
Mg1
2+ ion in the X-ray structure results in the lack of a coordination bond between the ATP Oγ
atom and Mg1
2+ ion, which causes the γ-phosphate of AMP-PNP to assume an unusual con-
formation. Therefore, the crystal structure of the GSK3β/AMP-PNP/2MG complex was also
aligned with the crystal structure of the pCDK9/cyclin T1/AMP-PNP/1MG/Tat complex to ex-
tract both AMP-PNP and Mg1
2+ ion coordinates into the pCDK9 ATP binding pocket. The
imido nitrogen atom was subsequently replaced with the oxygen atom, thus generating the
pCDK2/cyclin T1/ATP/2MG/Tat complex. The missing residues in the two CDK9 X-ray struc-
tures were completed using Molecular Operating Environment [31] and further minimized by
AMBER 11 [32] in the subsequent procedure. The detailed compositions of the five initial com-
plexes are summarized in Table 1.
Fig 1. Architecture of CDK9/cyclin T1. (A) Ribbon representation of the overall crystal structure of pCDK9/
cyclin T1 bound to ATP and one Mg2+ ion at site 2 (Mg2
2+ ion) complex (PDB code 3BLQ). (B) Ribbon
representation of the overall crystal structure of pCDK9/cyclin T1 bound to HIV-1 Tat and AMP-PNP and one
Mg2
2+ ion (PDB code 3MIA). CDK9 is purple blue, cyclin T1 is deep teal, and HIV-1 Tat is red. ATP,
AMP-PNP, and pThr186 are drawn as sticks, and Zn2+ ions and Mg2+ ions are drawn as yellow and green
spheres, respectively. The salt bridge network formed by pThr186 is shown as a red dotted line. (C) Structure
of ATP with labeled oxygen and nitrogen atoms used in this article.
doi:10.1371/journal.pone.0124673.g001
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Force Field
The AMBER force field (ff99SB) [33] was applied to the CDK9 protein, cyclin T1 protein,
HIV-1 Tat protein, and Mg2+ ions. Glu/Asp residues were deprotonated and Lys/Arg residues
were protonated at a simulated pH of 7. The protonated states for the His residues were as-
signed according to the PROPKA calculation, with the exception of the involvement of those
in the coordination with the zinc ion [His33 in the HIV-1 Tat coordinated to the zinc ion was
modeled as a negative charge state (−1 charge)]. We adopted the cationic dummy atom ap-
proach introduced by Pang et al. [34,35] to describe the zinc divalent cation. This approach
places four cationic dummy atoms in a tetrahedral arrangement in the zinc nucleus to mimic
the 4s4p3 vacant orbitals of the zinc ion. Thus, the lone-pair electrons of the zinc coordinates
occupy the vacant orbitals and fulfill the orientation requirements for the tetrahedral coordina-
tion geometry of zinc. The zinc nucleus was assigned with only van der Waals parameters (van
der Waals r = 3.1 Å, van der Waals potential well depth ε = 1E-6 kcal/mol, and charge q = 0),
whereas the dummy atom was assigned only with charge (r = 0, ε = 0, and q = 0.5e). The force
field parameters for the -2 charged pThr186 and the -4 charged ATP were taken from the
AMBER parameter database [36,37].
MD Simulations
The hydrogen atoms and the missing atoms were added to the Leap module of AMBER 11
[32]. Each system was immersed in the truncated octahedron box of TIP3P [38] water mole-
cules with a 10 Å buffer in each direction. An appropriate number of Cl- counterions were then
added through the random substitution of solvent water molecules with Cl- ions at the most fa-
vorable electrostatic potential positions to maintain the electroneutrality of the five systems.
Thus, the total number of atoms for Systems 1, 2, 3, 4, and 5 were 68110, 68297, 68308, 68309,
and 93339, respectively. Energy minimizations and MD simulations were conducted using the
SANDER module of AMBER 11 with periodic boundary conditions. Prior to the production
run, each system was optimized by using three steps minimization. First, ATP, metal ions, and
protein residues were fixed with harmonic force restraint, and only the positions of the water
molecules were minimized. Second, ATP, metal ions, and protein residues from crystal struc-
tures were constrained, whereas the added missing residues and water molecules were mini-
mized. Finally, the whole system was allowed to fully relax. In each step, energy minimization
was performed using the steepest descent method for the first 2500 steps and the conjugated
gradient method for the next 2500 steps. Each system was then gradually raised from 0 K to
300 K in a 50 ps canonical ensemble (NVT) heating process. Finally, 50 ns production MD
simulations were performed on the five systems in an isothermal isobaric ensemble (NPT) at a
constant pressure (1 atm) and constant temperature (300 K) by applying the Langevin algo-
rithm [39]. A cutoff equivalent to 10 Å was set for short-range electrostatics and van der Waals
interactions. Long-range electrostatic interactions were processed using the particle mesh
Ewald method [40] with cubic fourth-order B-spline interpolation and a 10–5 tolerance set for
Table 1. The compositions of the five simulations.
Complex System code Phosphorylaton state Composition
CDK9/cyclin T1/ATP/1Mg 1 Thr186 Dephosphorylated CDK9, cyclin T1, ATP, Mg2
2+
pCDK9/cyclin T1/ATP/1Mg 2 pThr186 Phosphorylated CDK9, cyclin T1, ATP, Mg2
2+
CDK9/cyclin T1/ATP/2Mg 3 Thr186 Dephosphorylated CDK9, cyclin T1, ATP, Mg1
2+, Mg2
2+
pCDK9/cyclin T1/ATP/2Mg 4 pThr186 Phosphorylated CDK9, cyclin T1, ATP, Mg1
2+, Mg2
2+
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the direct sum tolerance. An integration step of 2 fs was set for the MD simulations. All cova-
lent bonds involving hydrogen atoms were constrained at their equilibrium positions by the
SHAKE method [41] with a tolerance of 10–5 Å.
All the MD trajectories were subsequently analyzed using PTRAJ module. The 1 ps interval
saved coordinates were used to obtain the root-mean-square deviations (RMSDs), to calculate
the change in distance between two atoms, and to analyze H bonds. The criteria for forming an
H bond consists of an angle A-H-D larger than 120° and a distance between the acceptor atom
and the donor atom smaller than 3.5 Å.
Dynamic Cross-correlation Matrices
The Cα dynamic cross-correlation matrices (DCCM) were computed to reveal the correlative
motions of proteins [42]. C(i,j) was calculated as follows:
Cði; jÞ ¼ cði; jÞ
cði; iÞ1=2cðj; jÞ1=2
where C(i,j) is the covariance matrix element of the protein ﬂuctuation between residues i and
j.
The value of C(i,j) ranges from -1 to 1. Positive values suggest positively correlated move-
ment (the same direction), whereas negative values suggest anticorrelated movement (the op-
posite direction).
Results
System Stabilities during MD Simulations
Conventional MD simulations of five systems, CDK9/cyclin T1/ATP/1MG complex (System
1), pCDK9/cyclin T1/ATP/1MG complex (System 2), CDK9/cyclin T1/ATP/2MG complex
(System 3), pCDK9/cyclin T1/ATP/2MG complex (System 4), and pCDK9/cyclin T1/ATP/
2MG/Tat complex (System 5), were performed in explicit water for 50 ns. The Cα atom
RMSDs of the CDK9/cyclin T1 complexes in relation to the initial minimized structures as a
function of simulation time for five systems were monitored. As shown in Fig 2, after approxi-
mately 10 ns of simulation, the RMSDs tended to converge in Systems 1, 2, 3, 4, and 5 with val-
ues of 3.07 ± 0.37 Å, 2.71 ± 0.30 Å, 3.18 ± 0.25 Å, 2.95 ± 0.31 Å, and 2.94 ± 0.30 Å, respectively.
These values, along with the time dependence of total energies (data not shown), indicate that
the five systems achieved a state of equilibrium and were sufficient for exploring the dynamic
behavior of the studied systems.
Fig 2. Time dependence of Cα atoms RMSDs of CDK9/cyclin T1 for five simulations in the 50 ns MD simulations. Systems 1, 2, 3, 4, and 5 are shown
in black, red, blue, orange, and magenta, respectively. The same colors are maintained in the following Figs.
doi:10.1371/journal.pone.0124673.g002
The Roles of HIV-1 Tat and a SecondMagnesium Ion in the CDK9/CyclinT1
PLOS ONE | DOI:10.1371/journal.pone.0124673 April 24, 2015 6 / 23
Salt Bridge Network in the pThr186 Binding Site
Thr186 at the active loop is phosphorylated in three constructed simulation systems (Systems
2, 4, and 5). A cluster of three arginine residues, including Arg65 at the αC helix, Arg148 at the
catalytic loop, and Arg172 at the activation loop, constitutes the pThr186 binding site. System
5 contains HIV-1 Tat and features two salt bridges that were formed by Arg65 and Ary148 and
one salt bridge that was formed by Arg172. Negatively charged pThr186 served as the hub to
organize the positively charged triad. All five salt bridges were very stable throughout the simu-
lation time (Fig 3C). By contrast, in Systems 2 and 4 without HIV-1 Tat binding, the resulting
salt bridge networks were less stable. For example, in System 4, only one salt bridge was formed
Fig 3. Distances between phosphate group of pThr186 and guanidine group of arginine triad versus
simulation time. The distance between pThr186 and Arg65 are shown in black and gray, the distance
between pThr186 and Arg148 are shown in dark cyan and blue, and the distance between pThr186 and
Arg172 are represented as red in System 2 (A), System 4 (B), and System 5 (C). The salt bridges in the
pThr186 binding site at the 50 ns snapshot in three corresponding systems are shown in the right panel.
Residues involved in salt bridge formation (red dotted line) are described by the stick with a red oxygen atom,
blue nitrogen atom, and orange phosphorus atom.
doi:10.1371/journal.pone.0124673.g003
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by Arg65, and it was less stable than that in System 5 (Fig 3B). In the System 2, the salt bridge
formed between pThr186 and Arg65 was weakest (Fig 3A). Taken together, these data indicate
that both Mg1
2+ ion and HIV-1 Tat contributed to the stability of the salt bridge network
formed by pThr186.
Hydrogen Bonds in the ATP Binding Pocket
The hydrogen bonds formed by ATP with CDK9 are shown in Fig 4 and tabulated in Table 2.
Significant changes in ATP binding mode and ATP conformation were observed during simu-
lation. System 5 showed that H bonds were formed between Asp104 backbone carbonyl O
atom and ATP N6 atom, as well as between Cys106 backbone amide N atom and ATP N1
atom. As shown in Fig 5, these two H bonds were very stable in System 5 throughout simula-
tion process. By contrast, the same H bonds were all broken in the other four systems. The
breakage of these two H bonds resulted in the displacement of the adenine moiety of ATP from
its original position. The occupancy values (%) of H bonds formed between the Asp104 car-
bonyl O atom and the ATP N6 atom were 2.01, 5.99, 3.19, and 5.30 in Systems 1, 2, 3, and 4, re-
spectively, whereas those between the Cys106 amide N atom and the ATP N1 atom were 1.67,
5.40, 1.99, and 4.17, respectively. As shown in Fig 5, the rupture of the two H bonds between
the adenine moiety of ATP and the hinge residues of CDK9 occurred at approximately 1 ns in
nonphosphorylated Systems 1 and 3, and at approximately 2.7 ns in phosphorylated Systems 2
and 4. These observations suggest that the HIV-1 Tat is critical to the stabilization of H bonds
between the adenine moiety of ATP and the hinge residues Asp104 and Cys106 of CDK9. In
addition, another significant observation was related to the hydrogen bonding property of
Lys48. In System 5, the Lys48 side chain Nz atom was within the hydrogen bonding distance of
both the ATP Oα1 and Oβ2 atoms. However, in the systems occupied by one Mg
2+ (Systems 1
and 2), Lys48 was incapable of forming H bonds with ATP, whereas in the systems occupied
by two Mg2+ ions (Systems 3 and 4), Lys48 formed one H bond with the ATP N7 atom and one
H bond with the ATP Oα1 atom. The pivotal H bond between ATP and invariant Lys48
(ATP-Oβ2. . .HZ-NZ-Lys48), which is crucial to the enzymatic catalysis reaction, was broken in
all no HIV-1 Tat binding simulations (Table 2). This critical H bond causes the triphosphate
moiety of ATP to assume the correct orientation during simulations. Although Lys48 was inca-
pable of positioning its side chain in its optimal orientation in the two Mg2+ occupied systems
(Systems 3 and 4), the presence of Mg1
2+ ion contributed to the arrangement of Lys48 to obtain
one correct H bond, that is, ATP-Oα1. . .HZ-NZ-Lys48 interaction.
ATP Conformation in the ATP Binding Pocket
Apart from the differences in the formation of H bonds between ATP and CDK9 in various
systems, the simulations also indicated that the binding of both the Mg1
2+ ion and HIV-1 Tat
significantly reduced the magnitude of nanosecond timescale fluctuations in ATP phosphates.
The heavy atom RMSDs of ATP triphosphate moiety in the five systems in relation to its con-
formation in the initial minimized structure were monitored and calculated to be 0.89 ± 0.09 Å,
0.98 ± 0.04 Å, 0.72 ± 0.05 Å, 0.62 ± 0.04 Å, and 0.56 ± 0.06 Å for Systems 1, 2, 3, 4, and 5, re-
spectively (Fig 6A). The average RMSD values in the first two systems with one Mg2+ ion bind-
ing were higher than those in the remaining three systems with the binding of two Mg2+ ions,
which is consistent with the observed reorientation of the triphosphate moiety in Systems
1 and 2. With the Mg1
2+ ion at the binding pocket in Systems 3, 4, and 5, the additional magne-
sium-mediated ionic interactions reduced the conformation fluctuation of the ATP phos-
phates. In addition, HIV-1 Tat binding further reduced the triphosphate RMSD values. We
also analyzed the conformational change in the triphosphate moiety of ATP by monitoring the
The Roles of HIV-1 Tat and a SecondMagnesium Ion in the CDK9/CyclinT1
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dihedral Oα3-Pβ-Oβ3-Pγ and the distance between the Pα and Pγ atoms in the five simulation
systems as a function of time (Fig 6B and 6C). The values of dihedral Oα3-Pβ-Oβ3-Pγ in System
1 significantly fluctuated during simulation but were rather stable in the other four systems
(−98.56 ± 17.02°, 106.74 ± 7.86°, 91.84 ± 6.52°, and 97.21 ± 10.80° for Systems 2, 3, 4, and 5,
Fig 4. Hydrogen bonds and coordination bonds at the ATP binding pocket of CDK9 in five systems.
CDK9 is shown as a gray ribbon with a gray stick representing residues involved in hydrogen bond or
coordination bond. ATP is depicted by a yellow stick. All oxygen atoms, nitrogen atoms, and phosphate
atoms are depicted in red, blue, and orange, respectively. Mg1
2+ and Mg2
2+ ions are exhibited as green
spheres and water molecules are shown as red spheres. Red dotted lines indicate hydrogen bonds and blue
dotted lines represent coordination bonds.
doi:10.1371/journal.pone.0124673.g004
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respectively). The distances between the Pα and Pγ atoms were 3.78 ± 0.08 Å, 3.94 ± 0.07 Å,
3.99 ± 0.06 Å, 4.24 ± 0.06 Å, and 4.31 ± 0.06 Å in Systems 1, 2, 3, 4, and 5, respectively. In Sys-
tems 1 and 2, which lacked the Mg1
2+ ion, the dihedral angle Oα3-Pβ-Oβ3-Pγ and the distance
between the two phosphorus atoms (Pα and Pγ) were significantly different from those ob-
served in the binding systems with two Mg2+ ions.
Magnesium–Ligand Coordination
To analyze the magnesium–ligand coordination mode in our simulations, we compared our
simulation results with the X-ray crystal structures of CDK2. Yong et al. recently obtained sev-
eral ADP cocrystallized pCDK2/cyclin A structures [21,22]. Two of these structures comprise
pCDK2/cyclin A bound to ADP, substrate peptide, and trigonal-planar MgF3
- ion, a mimic for
the γ-phosphate of ATP (PDB code 3QHR and 3QHW), which are very similar to the TS com-
plexes. Two crystal structures (Fig 7B and 7C) showed Mg1
2+ ions that were coordinated by
one of the MgF3
- fluorine atoms, an ADP β-phosphate oxygen atom, two side chain carboxyl
oxygen atoms of Asp145 at the DFG motif, and oxygen atoms of two water molecules. Mg2
2+
ion also formed six coordination bonds with one of the MgF3
- fluorine atoms, ADP α- and β-
phosphate oxygen atoms, one carboxyl oxygen atom of Asp145, one side chain carbonyl oxy-
gen atom of Asn132, and one oxygen atom of water molecule. Each Mg2+ ion maintained a
hexa-coordinated octahedral geometry, which was also observed in the pCDK2/cyclin A com-
plex bound to ADP with one Mg2+ ion (PDB code 4II5) or with two Mg2+ ions (PDB code
Table 2. Summary of the average distances and occupancies of hydrogen bonds between ATP and CDK9 in five 50 ns simulated systems.
Systems Hydrogen bonds Occupancy (%) Distance (Å)
System1CDK9/cyclin T1/ATP/1MG ATP-O2*-H2'. . .O-Ala153 45.56 2.846±0.21
ATP-N7. . .H-N-Asp167 37.95 3.268±0.15
ATP-Oγ1. . .HZ-NZ-Lys151 70.38 3.025±0.23
ATP-Oγ2. . .HZ-NZ-Lys151 87.12 2.880±0.18
System2 pCDK9/cyclin T1/ATP/1MG ATP-O2*-H2'. . .O-Ala153 93.76 2.753±0.15
ATP-N6-H60. . .O-Cys106 63.18 2.990±0.18
ATP- Oγ1. . .HZ-NZ-Lys151 100.00 2.716±0.08
System3 CDK9/cyclin T1/ATP/2MG ATP-O2*-H2'. . .O-Ala153 67.47 2.798±0.16
ATP-O3*-H3'. . .O-Ala153 54.33 2.980±0.21
ATP-Oγ3. . .H21-ND2-Asn154 73.28 3.097±0.16
ATP-Oβ1. . .HG1-OG1-Thr29 95.43 2.645±0.11
ATP-Oβ1. . .H-N-Thr29 92.77 2.949±0.16
ATP-N7. . .HZ-NZ-Lys48 86.94 3.072±0.16
ATP-Oα1. . .HZ-NZ-Lys48 99.54 2.719±0.08
ATP-Oγ1. . .HZ-NZ-Lys151 63.34 2.762±0.11
System4 pCDK9/cyclin T1/ATP/2MG ATP-O2*-H2'. . .O-Ala153 81.63 2.797±0.17
ATP-Oβ1. . .H-N-Thr29 98.02 2.816±0.10
ATP-Oβ1. . .HG1-OG1-Thr29 98.07 2.738±0.16
ATP-N7. . .H-N-Asp167 60.15 3.254±0.15
ATP-N7. . .HZ3-NZ-Lys48 93.01 2.982±0.14
ATP-Oα1. . .HZ2-NZ-Lys48 97.12 2.707±0.08
System5 pCDK9/cyclin T1 /ATP/ 2MG/Tat ATP-N6-H60. . .O-Asp104 99.16 2.915±0.15
ATP-N1. . .H-N-Cys106 89.26 3.117±0.15
ATP-Oα1. . .HZ3-NZ-Lys48 99.83 2.711±0.08
ATP-Oβ2. . .HZ2-NZ-Lys48 80.51 2.973±0.16
doi:10.1371/journal.pone.0124673.t002
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4I3Z), as shown in Fig 7D and 7E, respectively. The difference is that the coordinated MgF3
-
fluorine atom in the 3QHR and 3QHW is replaced by the oxygen atom of water molecule in
the 4II5 and 4I3Z.
In simulation System 5 (Fig 7A), the Mg1
2+ ion also formed six coordination bonds with
ATP β- and γ-phosphate oxygen atoms, two side chain carboxyl oxygen atoms of invariant
Asp167 (Asp145 in CDK2) of the DFG motif, and two oxygen atoms of water molecules. Com-
pared with Mg1
2+ ion in the two CDK2 TS complex X-ray structures, five coordination bonds
were found to be similar, and only one coordination bond was different, that is, the γ-phos-
phate oxygen acted as a coordinating group in place of fluorine in MgF3
-.
An Mg2
2+ ion also exhibits hexa-coordinated octahedral geometry, but only five coordina-
tion bonds were observed during simulation. Mg2
2+ was coordinated to ATP α- and γ-phos-
phate oxygen atoms, a carboxyl oxygen atom of Asp167 (Asp145 in CDK2), a side chain
carbonyl oxygen of Asn154 (Asn132 in CDK2), and an oxygen atom in water. In this work, the
γ-phosphate oxygen, instead of β-phosphate oxygen, is a coordinating group, and an unoccu-
pied coordination position is observed. This position is occupied by fluorine ion in MgF3
- in
the CDK2 TS complex.
All three solvent water molecules involved in the coordination at the ATP binding pocket
rapidly reached their equilibrium positions at the beginning of the simulation in System 5 and
remained at their equilibrium positions at the end of 50 ns simulation, but no water molecule
Fig 5. Time dependence of the distances between adenine of ATP and Asp104/Cys106 in the five simulations. (A) The distance between Asp104
carbonyl O atom and ATP N6 atom; (B) The distance between Cys106 amide N atom and ATP N1 atom.
doi:10.1371/journal.pone.0124673.g005
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filled the unoccupied coordination position. This condition may be attributed to the fact that
the unoccupied position is required for CDK9 to achieve its TS. A possible scenario is that the
β-phosphate oxygen atom will form a coordination bond with Mg2
2+, whereas the cleaved γ-
Fig 6. Time dependence of RMSDs of ATP in five systems versus simulation time in the five systems. (A) The triphophate moiety of ATP. (B) The
dihedral Oα3-Pβ-Oβ3-Pγ. (C) The Pα and Pγ atoms of triphosphate moiety of ATP.
doi:10.1371/journal.pone.0124673.g006
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phosphate oxygen moves into the unoccupied coordination position to form another
coordination bond.
In binding simulation systems with two Mg2+ ions (Systems 3, 4, and 5), the second Mg2+
ion (Mg1
2+) formed six coordination bonds, similar to that observed in the three CDK2 crystal
structures (Fig 7). Lu et al. [43,44] showed that the hexa-coordinated octahedral geometry of
Mg2+ ion at site 1 was important for GSK3β activity, and dislodging this natural cofactor Mg2+
Fig 7. Schematic representation of the hydrogen bonds and coordination bonds in ATP active site in
System 5 and in four CDK2 X-ray structures. (A) pCDK9/cyclin T1/ATP/2MG/Tat complex in System 5, (B)
TS complex pCDK2/cyclinA/ADP/2MG/MgF3
-/peptide (PDB code 3QHR) solved at pH 8.0, (C) TS complex
pCDK2/cyclinA/ADP/2MG/MgF3
-/peptide (PDB code 3QHW) solved at pH 8.25, (D) pCDK2/cyclinA/ADP/
1MG complex (PDB code 4II5), (E) pCDK2/cyclinA/ADP/2MG complex (PDB code 4I3Z).
doi:10.1371/journal.pone.0124673.g007
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ion by a nonnative Ca2+ ion, which preferred a hepta-coordinated geometry, eliminated
enzymatic activity.
Critical Conformational Change
We superimposed the CDK9 subunit in pCDK9/cyclin T1/ATP/2Mg/Tat complex of System 5
with the CDK9 subunit in the other four systems to explore the critical conformation change of
CDK9, which results in the nonproductive binding of ATP. Upon closer inspection, the promi-
nent helix αC, a key structural element, was shifted in non-HIV-1 Tat binding systems. As
shown in Fig 8D, the unoccupied space above the activation loop in System 4 caused the activa-
tion loop to rotate upward, followed by the upward shift in the helix αC. As a consequence of
this conformational change, the position of two conserved hydrogen-bond interacting residues
(Glu66 and Lys48) that are important for the correct localization of ATP triphosphate were re-
located, which consequently caused Lys48 to form different H bonds with ATP. Systems 3 and
4 showed that Lys48 H bonds with Oα1 and N7 atoms instead of forming H bonds with Oα1
and Oβ2 atoms, as is the case in System 5. In the one Mg
2+ binding systems, the location and
conformation of ATP were altered to a greater degree than those in the two Mg2+ binding sys-
tems. The absence of Mg1
2+, ATP β-phosphate, and γ-phosphate oxygen atoms in Systems 1
and 2 were rotated and displaced, which were also demonstrated by the significant differences
in RMSDs of the triphosphate moieties and the dihedral angles Oα3-Pβ-Oβ3-Pγ. In System 1,
the helix αC moved forward instead of exhibiting the upward shift observed in the other three
systems. The side chain of Arg65 was curled in the nonphosphorylated systems, possibly be-
cause of charge repulsion.
Discussion
Phosphorylation of the activation loop is a prerequisite for kinase activation [45,46]. The ion
pairs between Arg65 and pThr186 in CDK9, between Arg50 and pThr160 in CDK2, and be-
tween His87 and pThr197 in catalytic subunit of PKA (PKAc) [47], which connect the activa-
tion loop of the C terminal lobe and helix αC of the N terminal lobe, are key structural
elements of active kinases. A more stable salt bridge network between pThr186 and the argi-
nine triad was formed in the presence of the HIV-1 Tat binding system. Notably, cyclin T1 in
the first four systems was based on one crystal structure (PDB code 3BLQ) [8], which included
three point mutations at residues Q77R, E96G, and F241L. By contrast, cyclin T1 in the last
system is based on a different crystal structure (PDB code 3MIA) [9] and is a wild-type protein.
Among the three mutations, E96G is located at the CDK/cyclin interface, and Glu96T1 was
found to form salt bridge interactions with Arg65CDK9 in System 5. To investigate the function
of Glu96T1 in the formation of Arg65–pThr186 ion pairs, we checked the twenty CDK9/cyclin
T1 crystal structures in the PDB database. Only seven of them contained wild-type Glu96 in cy-
clin T1. The crystal structures of seven CDK9/cyclin T1 complexes are listed in S1 Table and
the salt bridge network formed by Glu96T1, Arg65CDK9 and pThr186CDK9 are shown in S1 Fig.
Two Arg65–pThr186 ion pairs were observed in the four crystal structures with Tat binding
(PDB code 3MIA [9], 3MI9 [9], 4OGR [17], and 4OR5 [18]). The CDK9/cyclin T1 complex
binding to AFF4 scaffold (PDB code 4IMY [11]) showed the existence of an Arg65–pThr186
ion pair. In other non-Tat binding crystal structures, only one Arg65–pThr186 ion pair was
found in the crystal structure (PDB code 3TNH [10]), and no ion pair was detected in the
other crystal structure (PDB code 3TNI [10]). These data from crystal structures are consistent
with our MD simulation results, which suggested that only one less stable Arg65–pThr186 salt
bridge was formed in the complex owing to the absence of Tat binding. Schulze-Gahmen et al.
[11] have recently found that although HIV-1 Tat increases P-TEFb affinity for AFF4 scaffold,
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Fig 8. Superimposition of the CDK9 in snapshot at 50 ns in System 5 with those in the other four systems. (A) Superimposition of the CDK9 in System
1 (cyan) and System 5; (B) superimposition of the CDK9 in System 2 (magenta) and System 5; (C) superimposition of the CDK9 in System 3 (yellow) and
System 5; (D) superimposition of the CDK9 in System 4 (orange) and System 5. The pCDK9/cyclin T1 is gray and HIV-1 Tat is red in System 5. The hydrogen
bonds or salt bridges formed in System 5 are depicted by the red dotted line, and these interactions in other systems are described by the green dotted line.
doi:10.1371/journal.pone.0124673.g008
The Roles of HIV-1 Tat and a SecondMagnesium Ion in the CDK9/CyclinT1
PLOS ONE | DOI:10.1371/journal.pone.0124673 April 24, 2015 15 / 23
the structure of CDK9 kinase subunit structure did not show significant change upon AFF4
binding to P-TEFb and further addition of AFF2–73 did not stimulate the kinase activity of Tat-
P-TEFb complex. Taken together, these results demonstrate that the Glu96 in the cyclin T1
may contribute to the reorientation of the side chain of Arg65, but does not significantly affect
the interaction between Arg65 and pThr186. Therefore, HIV-1 Tat binding contributed to the
formation of a stable salt bridge network.
Although the conformation differences between the structures of pCDK9/cyclin T1/ATP/
1MG complex (PDB code 3BLQ) and pCDK9/cyclin T1/AMP-PNP/1MG/Tat complex (PDB
code 3MIA) were minor (RMSD = 1.220 Å), significant differences in dynamic behavior were
observed in the last two systems. Both the wild-type and triple mutant complexes have the
same KMapp'ATP value determined by Baumli et al. [10], which indicated that ATP binding was
unaffected by mutation. Therefore, the different dynamic behavior of Systems 4 and 5 can be
attributed to HIV-1 Tat binding. Repositioning of the helix αC is widely exploited to explore
the modulation of protein kinase activities. In this work, the shift of helix αC caused Glu66 and
its partner Lys48 to assume incorrect positions, thereby leading to the disruption of H bonds
between Lys48 Nz atom and ATP Oβ2 atom.
The presence of Mg1
2+, along with regulator HIV-1 Tat binding, accounted for the extreme-
ly similar architecture in CDK9 as that observed in some other kinase crystal structures con-
taining two metal ions and nonhydrolyzable ATP analog (or ADP). These structures include
pCDK2/cyclin A/ADP/2MG/MgF3
-/peptide complex (PDB code 3QHR [21]), GSK3β/
AMP-PNP/2MG complex (PDB code 1PYX [30]), MST3/ADP/2MN complex (PDB code 3A7J
[48]), PKAc/AMP-PCP/2MG complex (PDB code 4IAC [49]), PKB/AMP-PNP/2MN complex
(PDB code 1O6L [50]) and p38γ/AMP-PNP/2MG complex(PDB code 1CM8 [51]) (S2 Table).
Schematic representation of the H bonds and coordination bonds in the ATP active site of
these kinase crystal structures are shown in S2 Fig. All share similar binding mode between ki-
nase and ADP or ATP analog as that found in System 5. Adenine forms two H bonds with two
residues in hinge region. The Lys interacts with α- and β-phosphate oxygen atoms, and resi-
dues Asn and Asp coordinate to metal ions.
Many enzymes catalyze similar reactions that release the γ-phosphate from a nucleotide tri-
phosphate (NTP), but the number of catalytic metals is not always conserved. Myosin [52–53],
elongation factor Tu [54] and TIP49 AAA+ ATPase [55] have different ATP binding mode
and ATP hydrolysis mechanism is involved in a single Mg2+ ion. Also, there are two metal ions
captured in several crystal structures of catalytic subunit of cAMP-dependent kinase (PKAc),
including the reactant, PKAc/ATP/2MG complex (PDB code 4IAC [49]), the product, PKAc/
ADP/2MG complex (PDB code 4IAD, 4IAF [49]), and the transition state analog, PKAc/ADP/
AlF3/substrate peptide/2MG complex (PDB code 1L3R [56]). In the transition state of PKAc
(S3A Fig), the arrangement of the side chain oxygen atom of Ser in the substrate peptide
(OγSer-P), Al3+ ion and the oxygen atom of β phosphate is in line. In PKAc, the transition
states of the phosphoryl-transfer reaction have been classified as associative or dissociative
transition states. In the associative mechanism, one of the oxygen atoms of the γ phosphate
group to be transferred acts as a base, accepting the proton initially attached to OγSer-P [57].
In the dissociative mechanism, Asp166 residue serves as a catalytic base that accepts substrate
peptide proton during the phosphorylation process [58–60]. Although there are two disputed
phosphoryl-transfer mechanisms, OγSer-P has to attack ATP γ phosphorus in SN2-like reac-
tion, producing the direct displacement of the ADP moiety, without the involvement of any
solvent water. Alignment of the MD snapshot of System 5 with PKAc transition state analog is
shown in S3C Fig. With the engagement of both HIV-1 Tat and Mg1
2+, CDK9 in the System 5
established the catalytically-competent conformation as observed in the PKAc. Based on the
similar ATP binding mode and ATP catalytically-competent conformation obtained from the
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System 5, CDK9 may share a similar mechanism of phosphoryl-transfer reaction with its ho-
mologous protein PKAc.
The triphosphate moiety binding subpocket is extremely electronegative and includes a
number of conserved negative charges, such as Glu66 (Glu51 in CDK2), Glu149 (Glu127 in
CDK2), and Asp167 (Asp145 in CDK2). The two Mg2+ ions are utilized to accommodate the
phosphates into the active site environment. We modeled the second Mg2+ ion (Mg1
2+ ion at
site 1) in MD simulations to explore its functional role. Significant differences were found be-
tween one Mg2+ ion binding simulations and binding simulations of two Mg2+ ions in the
RMSDs of triphosphate moieties of ATP, the dihedral Oα3-Pβ-Oβ3-Pγ, and the distance be-
tween the Pα and Pγ atoms. Owing to the loss of Mg1
2+ mediated interaction with CDK9, the
triphosphate moiety was rotated and shifted in one Mg2+ ion binding simulations. Szarek et al.
[61] used the methodology of differential transition state stabilization to investigate the phos-
phoryl transfer reaction catalyzed by PKAc. They indicated that Mg2 (labeled Mg2
2+ in our
MD simulation) and Mg1 (labeled Mg1
2+ in our MD simulation) contributed -32.36 kcal/mol
and -15.15 kcal/mol to stabilize the transition state of PKAc, respectively. Zhao et al. [21]
found that Mg2+ concentration could represent an important regulator of CDK2 activity in
vivo. Furthermore, both of their data demonstrated that binding of the second Mg2+ ion ren-
dered ATP in more ordered conformation and in additional interactions with the protein. The
correct orientation and conformation of ATP triphosphate moiety is crucial to the phosphoryl-
transfer reaction between ATP γ-phosphate and the threonine hydroxyl group on the substrate,
which has been corroborated by experimental evidence and computational studies [62–68].
Our MD simulation study also provided convincing evidence that both Mg2+ ions are needed
for CDK9 to recruit ATP and localize the triphosphate moiety of ATP in the correct position
and conformation.
The DCCM for the five systems was further analyzed to determine the effect of the phos-
phorylated state of CDK9, Mg2+ ions, and HIV-1 Tat on the conformational motions of com-
plexes. Inspection of the nonphosphorylated states of CDK9 (Fig 9A and 9C) and the
phosphorylated states of CDK9 (Fig 9B, 9D and 9E) revealed that the nonphosphorylated states
of CDK9 displayed stronger anticorrelated motions than the phosphorylated states of CDK9.
These results indicate that phosphorylation of CDK9 has the potential to stabilize the confor-
mational plasticity of CDK9. A comparison between the one Mg2+ ion binding (Fig 9A) and
the two Mg2+ ion binding systems (Fig 9C) showed that the two Mg2+ ion binding system sig-
nificantly reduced the conformational motions relative to the one Mg2+ ion binding system.
However, this effect was not obviously observed in the phosphorylated states of CDK9 with
one Mg2+ ion binding (Fig 9B) and two Mg2+ ion binding systems (Fig 9D). In addition, when
compared with to the structure without HIV-1 Tat (Fig 9D), binding of HIV-1 Tat to the
CDK9/cyclin T1 complex reduced the conformational motions of complex (Fig 9E). Cumula-
tively, these data suggest that the phosphorylated state of CDK9, the second Mg2+ ion, and
HIV-1 Tat binding are capable of stabilizing the conformational flexibility of complexes.
Conclusions
The present MD simulations provided valuable insight into the functional roles of regulator
HIV-1 Tat and a second Mg2+ ion at site 1. HIV-1 Tat binding was is important to stabilize the
salt bridge network in the pThr186 binding site. HIV-1 Tat binding also occupied the space
above the activation loop, hence blocking upward shift of the activation loop. The strong
Arg65–pThr186 ion pair and steric hindrance fixed the prominent helix αC in its appropriate
position, which consequently resulted in the correct location of the highly conserved glutamate
residue Glu66 and its partner Lys48. The second Mg2+ ion at site 1 was required for CDK9 to
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realize its function. The ion had a crucial role to fix the triphosphate moiety in its appropriate
position by establishing coordination bonds with β- and γ-phosphate oxygen atoms. HIV-1
Tat binding, along with the appearance of two Mg2+ ions, resulted in an optimized
Fig 9. DCCM for System 1 (A), System 2 (B), System 3 (C), System 4 (D), and System 5 (E).
doi:10.1371/journal.pone.0124673.g009
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magnesium-ligand coordination mode and the reproduction of the active site architectural
characteristics in phosphorylated CDK9. The ATP binding mode in CDK9, which involves H
bonds between the adenine moiety of ATP and hinge region residues, H bonds formed by the
conserved residue Lys48 with the Oα1 and Oβ2 atoms of ATP, and the hexa-coordinated octa-
hedral geometry of Mg2+ with conserved residues Asp167 (Asp145) and Asn154 (Asn132), is
very similar to the conformation captured in crystal structures of the pCDK2/cyclin A TS com-
plex. All these results provide significant insight into the CDK activation/regulation processes
and might help with the design of P-TEFb inhibitors to target HIV-1 transcription.
Supporting Information
S1 Fig. The salt bridge network formed by Glu96T1, Arg65CDK9 and pThr186CDK9 in 7 crys-
tal structures of CDK9/cyclin T1 complex. (A) pCDK9/cyclin T1/Tat/AMP-PNP complex
(PDB code 3MIA) (B) pCDK9/cyclin T1/Tat complex (PDB ID 3MI9), (C) pCDK9/cyclin T1/
Tat/AFF4/adenosine complex (PDB code 4OGR), (D) pCDK9/cyclin T1/Tat/AFF4 complex
(PDB code 4OR5), (E) pCDK9/cyclin T1/AFF4/AMP complex (PDB code 4IMY), (F) pCDK9/
cyclin T1/CAN508 complex(PDB code 3TNH) and (G) pCDK9/cyclin T1 complex (PDB code
3TNI). CDK9, cyclin T1 and HIV-1 Tat are shown in grey, magenta and red ribbon, respective-
ly. The Arg65, pThr186 and Glu96 are drawn as sticks. The salt bridges are shown as red
dotted lines.
(TIF)
S2 Fig. Schematic representation of the hydrogen bonds and coordination bonds in ATP
active site in kinase crystal structures containing 2 metal ions and ATP analog. (A) pCDK2/
cyclin A/ADP/2MG/MgF3
-/peptide complex (PDB code 3QHR), (B) GSK3β/AMP-PNP/2MG
complex (PDB code 1PYX), (C) MST3/ADP/2MN complex (PDB code 3A7J), (D) PKAc/
AMP-PCP/2MG complex (PDB code 4IAC), (E) PKB/AMP-PNP/2MN complex (PDB code
1O6L), (F) p38γ/AMP-PNP/2MG complex (PDB code 1CM8).
(TIF)
S3 Fig. Alignment of MD snapshot of System 5 with PKAc transition state analog. (A)
PKAc/ADP/AlF3/substrate peptide/2MG complex (PDB code 1L3R), (B) MD snapshot of Sys-
tem 5, (C) the alignment of MD snapshot of System 5 with PKAc transition state analog.
(TIF)
S1 Table. The compositions of 7 crystal structures of CDK9/cyclin T1 complex.
(DOCX)
S2 Table. Kinase crystal structures containing 2 metal ions and ATP analog.
(DOCX)
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